Ketamine Safety Resources
Safety-focused ketamine therapy articles covering contraindications, side effects, monitoring, emergency planning, medication interactions, and misuse prevention.
Read before treatment
Use this hub to identify topics to discuss with a licensed clinician before starting or changing care.
Contact Low Dose Ketamine
Send corrections, provider questions, or advertising inquiries.
Featured
3 articles
Ketamine and Liver Function Tests: Monitoring LFTs During Therapy
A clinical guide to liver function test monitoring during low-dose ketamine therapy, including baseline assessment, frequency of testing, interpreting abnormal results, and managing hepatotoxicity risk.
Low-Dose Ketamine and Alcohol: Patient Safety Guide
A safety-focused guide on the risks and clinical considerations of alcohol use during ketamine therapy, covering pharmacological interactions, metabolism, timing guidelines, and patient counseling strategies.
Ketamine and SSRIs: Drug Interaction Deep Dive
Can patients take SSRIs during low-dose ketamine therapy? Review of pharmacodynamic overlap, serotonin syndrome signals, and co-prescribing patterns.
Ketamine and Liver Function Tests: Monitoring LFTs During Therapy
A clinical guide to liver function test monitoring during low-dose ketamine therapy, including baseline assessment, frequency of testing, interpreting abnormal results, and managing hepatotoxicity risk.
Low-Dose Ketamine and Alcohol: Patient Safety Guide
A safety-focused guide on the risks and clinical considerations of alcohol use during ketamine therapy, covering pharmacological interactions, metabolism, timing guidelines, and patient counseling strategies.
Ketamine and SSRIs: Drug Interaction Deep Dive
Can patients take SSRIs during low-dose ketamine therapy? Review of pharmacodynamic overlap, serotonin syndrome signals, and co-prescribing patterns.
Ketamine and Benzodiazepines: Clinical Interaction Guide
How do benzodiazepines affect low-dose ketamine response? Review of GABAergic blunting, pre-session timing, taper considerations, and clinical findings.
Is Ketamine Therapy Addictive?
When administered in a supervised clinical setting at low doses, ketamine therapy carries a low risk of addiction, though the drug does have abuse potential.
How Long Do Ketamine Side Effects Last?
Most ketamine side effects resolve within 1 to 2 hours after an infusion ends, with subtle residual effects fading within 4 to 6 hours.
Can You Drive After Ketamine Treatment?
When is it safe to drive after a low-dose ketamine session? Review of dissociation timing, cognitive recovery windows, and clinic discharge guidance.
Ketamine and Blood Pressure: What Patients Should Know
A patient-oriented clinical guide to understanding ketamine's effects on blood pressure, including why blood pressure rises during treatment, what levels are expected, who is at increased risk, and how clinicians manage cardiovascular responses.
Ketamine and Bladder Health: Urological Safety at Therapeutic Doses
Does low-dose ketamine cause bladder problems? Review of urological risk at therapeutic vs recreational doses, mechanisms, and monitoring recommendations.
Ketamine in Pregnancy and Lactation: Safety Considerations and Data Gaps
What do we know about low-dose ketamine in pregnancy and lactation? Review of safety data, placental transfer, breastfeeding considerations, and evidence gaps.
Abuse Potential of Therapeutic Ketamine: Risk Stratification and Monitoring
Assessment of abuse potential for therapeutic ketamine, examining risk stratification approaches, monitoring strategies, and safeguards for clinical prescribing programs.
Ketamine Side Effects: A Complete Clinical Guide
Comprehensive evidence-based review of ketamine side effects including dissociation, nausea, cardiovascular changes, and cognitive effects for clinicians.
Ketamine Tolerance and Long-Term Use: What Clinicians Need to Know
Clinical review of tolerance development during long-term ketamine therapy, including mechanisms, detection strategies, and evidence-based management approaches.
Managing Nausea and Vomiting During Ketamine Therapy
Clinical guide to preventing and treating ketamine-induced nausea and vomiting, covering antiemetic protocols, risk factors, and non-pharmacological strategies.
Cognitive Effects of Repeated Low-Dose Ketamine: Neuropsychological Assessment
Does repeated low-dose ketamine affect cognition? Review of memory, attention, and executive function testing across short- and longer-term treatment courses.
Ketamine-Associated Hepatotoxicity: Risk Factors and Liver Function Monitoring
Review of ketamine-associated hepatotoxicity including risk factors, proposed mechanisms, liver function monitoring protocols, and clinical management for repeated therapeutic dosing.
Cardiovascular Effects of Low-Dose Ketamine: Hemodynamic Monitoring Guidelines
Evidence-based hemodynamic monitoring guidelines for low-dose ketamine, covering sympathomimetic cardiovascular effects, blood pressure management, and cardiac risk stratification.
Long-Term Safety Considerations for Ketamine Therapy
What is known about long-term low-dose ketamine safety? Review of cumulative exposure data, organ-specific monitoring, and gaps in multi-year evidence.
Contraindications and Screening Protocols for Ketamine Therapy
A thorough guide to absolute and relative contraindications for low-dose ketamine, along with recommended screening protocols encompassing medical history, psychiatric evaluation, laboratory assessment, and informed consent procedures.